Itovebi Tablet, Film Coated
Product Images NDC 50242-079

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Itovebi (NDC 50242-079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Inavolisib 01)

Chemical structure of the active ingredient in Itovebi, depicting its molecular arrangement including an amino acid moiety, fluorinated cyclic structure, and fused heterocyclic rings.*

FDA Label Image

Figure 1 (Inavolisib 02)

A Kaplan-Meier curve chart comparing progression-free survival probabilities over time in months for two treatment groups: ITOVEBI plus palbociclib plus fulvestrant versus placebo plus palbociclib plus fulvestrant. The graph includes a table of patients at risk at various time points up to 36 months, with censoring marks indicated on the curves.*

FDA Label Image

Principal Display Panel (9 mg Tablet Bottle Carton)

Itovebi 9 mg tablets packaging label displaying the proprietary name, active ingredient inavolisib, and strength. The label includes instructions to swallow tablets whole and not to chew, crush, or split them. The package contains 28 tablets and is labeled by Genentech, Inc.*

FDA Label Image

Principal Display Panel (3 mg Tablet Bottle Carton)

Label for Itovebi (inavolisib) 3 mg tablets by Genentech, Inc. The label includes instructions to swallow tablets whole and not to chew, crush, or split them. The package contains 28 tablets and displays the NDC 50242-084-08.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.